Erste Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.35M Buy
2025
Q1
$2.69M Hold
2024
Q4
$3.32M Hold
2024
Q3
$2.74M Hold
2024
Q2
$3.2M Hold
2024
Q1
$3.28M Hold
2023
Q4
$3.15M Hold
2023
Q3
$2.74M Hold
2023
Q2
$2.25M Hold
2023
Q1
$2.36M Hold
2022
Q4
$2.86M Hold
2022
Q3
$2.45M Hold
2022
Q2
$2.34M Hold
2022
Q1
$2.2M Sell
2021
Q4
$2.1M Hold
2021
Q3
$2.35M Hold
2021
Q2
$2.41M Hold
2021
Q1
$2.35M Hold
2020
Q4
$2.34M Sell
2020
Q3
$3.88M Hold
2020
Q2
$4.98M Hold
2020
Q1
$3.64M Sell
2019
Q4
$12.3M Buy
2019
Q3
$8.72M Sell
2019
Q2
$8.76M Sell
2019
Q1
$9.21M Sell
2018
Q4
$8.44M Buy